mesa laboratories, inc., develops, manufactures and markets high-quality process validation, monitoring and calibration instruments and consumables worldwide. mesa offers quality data loggers for monitoring temperature, humidity, and pressure and biological indicators (bis) for medical device and pharmaceutical manufacturing sterilization monitoring. the datatrace data loggers and mesa bis are available to monitor and validate applications including steam and eo sterilization, autoclave validation, incubators, heat tunnels and more. mesa’s bi offering also includes bis for industrial use, hydrogen peroxide (h2o2), chlorine dioxide and more. the phoenix meter is a point-of-use dialysate qc meter used prior to each procedure. the 90xl meter is the industry standard for calibration of dialysis machines in the field. also available are industry leading nist-traceable calibration solutions. mesa also offers cap torque testers which are durable, reliable and computerized cap torque analyzers
Company profile
Ticker
MLAB
Exchange
Website
CEO
Gary Owens
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Danaher • Roper • Fortive • Ametek • Sensata Technologies Holding • Keysight • MKS Instruments • Cognex • Hurco Companies • Sypris Solutions ...
Former names
MESA LABORATORIES INC /CO
SEC CIK
Corporate docs
Subsidiaries
Agena Bioscience GmbH • Agena Bioscience, Inc. • Gyros DE GmbH • Gyros Finans AB • Gyros France Sarl • Gyros Patent AB • Gyros Protein Technology AB • Gyros Protein Technology Holding AB • Gyros U.K. Ltd. • Gyros U.S. Inc. ...
IRS number
840872291
MLAB stock data
Latest filings (excl ownership)
10-Q
2024 Q3
Quarterly report
5 Feb 24
8-K
Mesa Labs Announces Third Quarter Results
5 Feb 24
8-K
Mesa Laboratories Appoints Mark Capone to its Board of Directors
8 Jan 24
10-Q
2024 Q2
Quarterly report
6 Nov 23
8-K
Mesa Labs Announces Second Quarter Results
6 Nov 23
8-K
Mesa Labs Acquires GKE-GmbH
18 Oct 23
8-K
Entry into a Material Definitive Agreement
10 Oct 23
8-K
Changes in Registrant's Certifying Accountant
30 Aug 23
S-8
Registration of securities for employees
30 Aug 23
8-K
Amendments to Articles of Incorporation or Bylaws
25 Aug 23
Latest ownership filings
4
Mark Christopher Capone
16 Feb 24
3
Mark Christopher Capone
16 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
ROYCE & ASSOCIATES LP
23 Jan 24
SC 13G/A
BlackRock Inc.
22 Jan 24
SC 13G/A
Conestoga Capital Advisors, LLC
5 Jan 24
4
Brian David Archbold
19 Dec 23
144
Notice of proposed sale of securities
15 Dec 23
4
John James Sullivan
14 Nov 23
4
John Bradley Schmieder
19 Sep 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 35.62 mm | 35.62 mm | 35.62 mm | 35.62 mm | 35.62 mm | 35.62 mm |
Cash burn (monthly) | (no burn) | (no burn) | 441.67 k | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | n/a | 2.49 mm | n/a | n/a | n/a |
Cash remaining | n/a | n/a | 33.13 mm | n/a | n/a | n/a |
Runway (months of cash) | n/a | n/a | 75.0 | n/a | n/a | n/a |
Institutional ownership, Q3 2023
86.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 150 |
Opened positions | 16 |
Closed positions | 24 |
Increased positions | 52 |
Reduced positions | 54 |
13F shares | Current |
---|---|
Total value | 484.54 bn |
Total shares | 4.66 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 805.75 k | $84.66 bn |
Conestoga Capital Advisors | 530.21 k | $55.71 bn |
Vanguard | 363.00 k | $38.14 bn |
MS Morgan Stanley | 243.35 k | $25.57 bn |
Ranger Investment Management | 223.99 k | $23.53 bn |
STT State Street | 183.53 k | $19.28 bn |
Royce & Associates | 166.02 k | $17.44 bn |
PFG Principal Financial Group Inc - Registered Shares | 154.77 k | $16.26 bn |
Kayne Anderson Rudnick Investment Management | 144.11 k | $15.14 bn |
Dimensional Fund Advisors | 128.00 k | $13.45 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Feb 24 | Mark Christopher Capone | RSU Common Stock | Grant | Acquire A | No | No | 0 | 724 | 0.00 | 724 |
15 Dec 23 | Archbold Brian David | Common Stock | Sell | Dispose S | No | Yes | 112.36 | 1,500 | 168.54 k | 558 |
9 Nov 23 | Sullivan John James | Common Stock | Gift | Dispose G | No | No | 0 | 2,000 | 0.00 | 26,804 |
9 Nov 23 | Sullivan John James | Common Stock | Gift | Acquire G | Yes | No | 0 | 200 | 0.00 | 44,780 |
9 Nov 23 | Sullivan John James | Common Stock | Gift | Dispose G | No | No | 0 | 200 | 0.00 | 28,804 |
15 Sep 23 | Schmieder John Bradley | Common Stock | Sell | Dispose S | No | Yes | 123.74 | 1,000 | 123.74 k | 62,760 |
14 Sep 23 | Schmieder John Bradley | Common Stock | Sell | Dispose S | No | No | 123.05 | 3,000 | 369.15 k | 63,760 |
News
Mesa Laboratories Q3 Adjusted EPS $2.02 May Not Be Comparable To $0.19 Estimate, Sales $53.47M Miss $54.89M Estimate
5 Feb 24
Earnings Scheduled For February 5, 2024
5 Feb 24
Earnings Preview: Mesa Laboratories
2 Feb 24
Evercore ISI Group Upgrades Mesa Laboratories: Here's What You Need To Know
4 Jan 24
Evercore ISI Group Upgrades Mesa Laboratories to Outperform, Raises Price Target to $125
4 Jan 24